GW&K Investment Management LLC lifted its position in shares of Silicon Laboratories (NASDAQ:SLAB) by 13.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 745,663 shares of the semiconductor company’s stock after purchasing an additional 87,338 shares during the period. Silicon Laboratories comprises about 1.2% of GW&K Investment Management LLC’s holdings, making the stock its 6th largest position. GW&K Investment Management LLC owned 1.72% of Silicon Laboratories worth $83,029,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quest Capital Management Inc. ADV acquired a new stake in shares of Silicon Laboratories during the third quarter worth about $39,000. NumerixS Investment Technologies Inc acquired a new stake in shares of Silicon Laboratories during the second quarter worth about $93,000. Tower Research Capital LLC TRC increased its position in shares of Silicon Laboratories by 832.7% during the second quarter. Tower Research Capital LLC TRC now owns 998 shares of the semiconductor company’s stock worth $104,000 after purchasing an additional 891 shares in the last quarter. Sun Life Financial INC acquired a new stake in shares of Silicon Laboratories during the second quarter worth about $117,000. Finally, Ladenburg Thalmann Financial Services Inc. increased its position in shares of Silicon Laboratories by 23.5% during the second quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,499 shares of the semiconductor company’s stock worth $155,000 after purchasing an additional 285 shares in the last quarter. Institutional investors and hedge funds own 92.86% of the company’s stock.
Shares of NASDAQ SLAB traded up $0.44 during midday trading on Friday, reaching $109.00. 169,800 shares of the company were exchanged, compared to its average volume of 303,703. The company has a current ratio of 6.78, a quick ratio of 6.24 and a debt-to-equity ratio of 0.34. Silicon Laboratories has a 1 year low of $73.13 and a 1 year high of $115.29. The stock has a market cap of $4.85 billion, a P/E ratio of 38.11, a PEG ratio of 3.16 and a beta of 1.49. The stock has a fifty day simple moving average of $109.83 and a 200 day simple moving average of $105.11.
Silicon Laboratories (NASDAQ:SLAB) last issued its quarterly earnings data on Wednesday, October 23rd. The semiconductor company reported $0.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.84 by $0.12. Silicon Laboratories had a return on equity of 9.33% and a net margin of 2.96%. The firm had revenue of $223.30 million during the quarter, compared to the consensus estimate of $217.97 million. During the same period in the previous year, the firm posted $1.01 EPS. The company’s quarterly revenue was down 3.0% compared to the same quarter last year. As a group, analysts forecast that Silicon Laboratories will post 2.21 earnings per share for the current year.
A number of research firms have recently commented on SLAB. Benchmark began coverage on Silicon Laboratories in a research report on Tuesday, July 23rd. They set a “buy” rating and a $120.00 target price on the stock. ValuEngine lowered Silicon Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. BidaskClub lowered Silicon Laboratories from a “buy” rating to a “hold” rating in a report on Friday, November 1st. TheStreet raised Silicon Laboratories from a “c+” rating to a “b-” rating in a report on Wednesday, October 23rd. Finally, Zacks Investment Research raised Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Friday, October 25th. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $113.38.
In other Silicon Laboratories news, CEO George Tyson Tuttle sold 36,813 shares of the business’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $112.86, for a total value of $4,154,715.18. Following the completion of the transaction, the chief executive officer now directly owns 212,779 shares in the company, valued at approximately $24,014,237.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Brandon Tolany sold 1,000 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $113.94, for a total value of $113,940.00. Following the completion of the transaction, the senior vice president now owns 48,758 shares of the company’s stock, valued at $5,555,486.52. The disclosure for this sale can be found here. Insiders have sold a total of 48,813 shares of company stock valued at $5,472,005 over the last 90 days. Insiders own 2.10% of the company’s stock.
Silicon Laboratories Profile
Silicon Laboratories Inc, a fabless semiconductor company, designs, develops, and markets mixed-signal integrated circuits (ICs) in the United States, China, and internationally. The company offers Internet of things products, including 8-bit mixed-signal, 32-bit wireless, and ultra-low-power 32-bit microcontrollers; wireless connectivity devices, such as multiprotocol wireless Gecko system-on-chip devices; real-time operating systems; sensor products comprising optical, relative humidity/temperature, and hall effect magnetic sensors.
Recommended Story: What is a balanced fund?
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.